Pathstone Holdings Portfolio holdings
AUM
$25.3B
1-Year Return
20.32%
This Quarter Return
+12.29%
1 Year Return
+20.32%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$18.4B
AUM Growth
–
Cap. Flow
+$18.4B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
33.3%
Holding
2,196
New
2,196
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.08B |
| 3 |
Microsoft
MSFT
|
+$846M |
| 4 |
Apple
AAPL
|
+$599M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$589M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 17.16% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 5.58% |
| 4 | Healthcare | 4.6% |
| 5 | Consumer Staples | 3.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Fox Class B
FOX
$23.1B
| $360K | ﹤0.01% |
+13,027
| New | +$360K |
|
1702
Urban Edge Properties
UE
$2.64B
| $360K | ﹤0.01% |
+19,633
| New | +$360K |
|
1703
Cirrus Logic
CRUS
$5.78B
| $360K | ﹤0.01% |
+4,326
| New | +$360K |
|
1704
Polaris
PII
$3.29B
| $359K | ﹤0.01% |
+3,790
| New | +$359K |
|
1705
Rayonier
RYN
$4.04B
| $359K | ﹤0.01% |
+11,281
| New | +$359K |
|
1706
Central Garden & Pet Class A
CENTA
$2.07B
| $358K | ﹤0.01% |
+10,171
| New | +$358K |
|
1707
IQ MacKay Municipal Insured ETF
MMIN
$341M
| $358K | ﹤0.01% |
+14,566
| New | +$358K |
|
1708
Incyte
INCY
$16.8B
| $357K | ﹤0.01% |
+5,688
| New | +$357K |
|
1709
Barrett Business Services
BBSI
$1.18B
| $357K | ﹤0.01% |
+12,316
| New | +$357K |
|
1710
Installed Building Products
IBP
$7.21B
| $357K | ﹤0.01% |
+1,950
| New | +$357K |
|
1711
J&J Snack Foods
JJSF
$2.08B
| $356K | ﹤0.01% |
+2,129
| New | +$356K |
|
1712
EA Bridgeway Omni Small-Cap Value ETF
BSVO
$1.73B
| $355K | ﹤0.01% |
+16,897
| New | +$355K |
|
1713
Vita Coco
COCO
$2.19B
| $355K | ﹤0.01% |
+13,843
| New | +$355K |
|
1714
Mattel
MAT
$5.78B
| $355K | ﹤0.01% |
+18,780
| New | +$355K |
|
1715
Adtalem Global Education
ATGE
$4.79B
| $353K | ﹤0.01% |
+5,993
| New | +$353K |
|
1716
LanzaTech
LNZA
$45.4M
| $352K | ﹤0.01% |
+701
| New | +$352K |
|
1717
Royalty Pharma
RPRX
$15.6B
| $352K | ﹤0.01% |
+12,492
| New | +$352K |
|
1718
Amphastar Pharmaceuticals
AMPH
$1.32B
| $351K | ﹤0.01% |
+5,683
| New | +$351K |
|
1719
TKO Group
TKO
$16B
| $350K | ﹤0.01% |
+4,294
| New | +$350K |
|
1720
Performance Food Group
PFGC
$16.3B
| $350K | ﹤0.01% |
+5,063
| New | +$350K |
|
1721
Westlake Corp
WLK
$10.9B
| $349K | ﹤0.01% |
+2,495
| New | +$349K |
|
1722
Innospec
IOSP
$2.06B
| $349K | ﹤0.01% |
+2,832
| New | +$349K |
|
1723
SAB Biotherapeutics
SABS
$22.3M
| $348K | ﹤0.01% |
+50,651
| New | +$348K |
|
1724
Scholastic
SCHL
$660M
| $348K | ﹤0.01% |
+9,231
| New | +$348K |
|
1725
BioLife Solutions
BLFS
$1.27B
| $347K | ﹤0.01% |
+21,352
| New | +$347K |
|